Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2026-05-19 @ 10:05 AM
Study NCT ID:
NCT02556203
Status:
TERMINATED
Last Update Posted:
2020-01-13
First Post:
2015-09-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
Sponsor:
Bayer
Organization: